Navigating the landscape of end-of-life care and access to medications like Nembutal in New South Wales, Australia, requires a careful understanding of the complex legal structure. Currently, Pentobarbital does not have a official place on the Pharmaceutical Benefits Scheme (this program) and is therefore not commonly prescribed by healthcare profe